#USA #New York #Inc. #Embolization #Vascular Embolization #NED coil

Exciting Innovations in Vascular Embolization from Embolization, Inc.

Introduction

Embolization, Inc. will introduce its cutting-edge vascular embolization device, highlighting the NED coil at the Annual GEST Conference from May 14-17, 2026, in New York, specifically at Booth No. 403. This device utilizes proprietary shape-memory biocompatible polymers, setting it apart from traditional metal coils.

Addressing Imaging Challenges

One of the most significant advancements the NED coil offers is its ability to minimize artifacts seen in CT and MRI imaging, commonly associated with metal coils. As noted by CEO Jim Kasic, this device not only enhances vascular occlusion effectiveness but also preserves imaging clarity, allowing for improved diagnostic accuracy.

FDA Clearance

What makes the NED coil particularly remarkable is its FDA 501(k) clearance, affirming it as the first polymer-based coil available on the market. In contrast, existing coils predominantly consist of metal elements. Despite minimizing artifacts on imaging scans, these innovative coils are still radiopaque during fluoroscopy, ensuring visibility in critical situations.

Performance and Clinical Benefits

Recent studies indicate that the NED coil results in shorter occlusion times, thereby increasing efficiency in procedures. The design allows for tighter coil packs, which can lead to fewer devices required per procedure, ultimately driving down both recanalization rates and manufacturing costs. According to Kasic, "The NED has the capability to perform all functions of traditional metal coils but does so with the added advantages of a state-of-the-art radiopaque polymer."

Success in Limited-Market Release

Since its limited-market rollout, the NED coil has achieved considerable success, with over 70 coils utilized in various medical institutions. Clinical evaluations reveal consistent efficacy across a diverse patient demographic, including both males and females aged 21-80, across diverse venous and arterial applications.

Advantages of the Non-Metal Coil

The non-metal coil offers numerous clinical benefits, including:

• - Reduction in imaging obstructions: Users reported significantly less shadowing or obscuration on imaging scans, aiding in more accurate diagnostics.
• - Easier repeat procedures: The coil's design allows for straightforward repeat embolizations without compromising patient safety.
• - Faster, reliable embolization: Enhanced efficiency and performance are hallmarks of this novel implant.
• - Simplicity in operation: With the patented 1mm diameter implantation tool, usage is straightforward, streamlining the procedural workflow.

Engagement Opportunities at GEST

Kasic expressed enthusiasm about presenting at GEST, viewed as a premier educational platform for interventional radiology and oncology. This event provides an excellent opportunity to engage with industry experts and highlight the innovative aspects of the new embolic coils.

For those interested in discussing the NED coil further or scheduling a meeting with Kasic or Embolization's regulatory consultant, Madeline Kasic is available at [email protected] or 303-531-1238, Ext. 718.

About Embolization, Inc.

Based in Boulder, Colorado, Embolization, Inc. specializes in creating advanced medical devices that utilize radiopaque shape-memory biocompatible polymers. The firm is dedicated to developing minimally invasive devices for both peripheral vascular and neurovascular applications. For further inquiries, media contact Aimee Bennett at [email protected] or via phone at 303-843-9840.

Conclusion

the NED coil represents a significant breakthrough in the field of vascular embolization, promising both clinical performance and operational benefits. As Embolization, Inc. prepares for its showcase at GEST, the excitement surrounding this transformative device continues to grow.